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There is much to suggest that certain of the biologic effects of endotoxins of 
Gram-negative bacteria are consequences of a reaction involving blood plate- 
lets.  Thromhocytopenia  occurring  after  injection  of endotoxin is  well  docu- 
mented  (1, 2) and is associated with the appearance of platelet aggregates in 
pulmonary  arterial  blood  (3).  Concomitantly  5-hydroxytryptamine  (5HT), 
which  normally  circulates  virtually  completely bound  to platelets  in  an  in- 
active form, appears in plasma in appreciable quantities (4-6). These observa- 
tions suggest that the interaction of endotoxin and platelets in vivo results in 
platelet  aggregation,  trapping  of  these  aggregates  in  vascular  beds,  and  a 
transfer  of  pharmacologically  active  platelet  factors,  including  5HT,  from 
platelets  to plasma.  The  studies  to be reported herein  indicate that  platelet 
aggregation and transfer of 5HT from platelets to plasma can also be observed 
in  vitro during  the  course of incubation  of platelet-rich  rabbit  plasma  with 
endotoxin. In addition,  two other platelet factors, platelet phospholipid and a 
heat-stabile  bactericidin  active  against  Bacillus  subtilis,  are  liberated  from 
platelets during incubation with endotoxin. 
Materials and Methods 
All glassware was freshly siliconized by immersion in a  1:1000 dilution of Dow Coming 
Z4141 for 1 hour and was baked for 2 hours at 170°C prior to use. An Escher~hia coli endo- 
toxin of the Boivin type  (Difco E. coli endotoxin lot 0127:B8)  suspended in saline solution 
to a concentration of 2 mg per ml was used in all experiments. Several preparations bearing 
different control numbers of this lot of endotoxin were used and were found to vary some- 
what in activity. 
* This work was supported by grants from the United States Public Health Service (Grants 
H3479 and H5746) and by the Health Research Council of The City of New York under Con- 
tract U-1107. 
:~ Edward Livingston Trudeau Fellow of the American Thoracic Society. 
857 858  BACTERIAL  ENDOTOXIN  AND  RABBIT  PLATELETS.  I 
Assay  of 5HT.--SHT content of plasma and platelets was determined by the estrus rat 
uterus bioassay system of Erspamer (7) using a freshly prepared low calcium (20 mg per liter) 
Ringer's solution in a  10 ml muscle bath.  Amounts of 5 HT required for threshold response 
varied from 15 to 50 NG (1 NG =  0.001 #g) and maximum responses occurred with from 50 
to 200 NG. Both speed of onset and amplitude of contraction were measured and in almost 
all instances varied directly with each other. In the present studies, amplitude was used as 
the criterion of response.  Differences as small as 10 NG could be measured with accuracy by 
bracketing the test response with responses to known quantities of 5HT. Standards of 5HT 
were prepared from frozen stock solutions containing 1 mg serotonin creatinine sulfate (Sandoz 
Corporation,  Hanover, New Jersey) per ml of Ringer's solution. Stock 5HT solutions were 
kept no longer than  1 month. When specimens for assay contained large amounts of 5HT, a 
considerable error was introduced by the large dilution factor necessary to bring the 5HT 
concentration within the relatively narrow range of the assay. 
The specificity of the assay for 5HT was determined as follows: (a) The uterus-stimulating 
activity in plasma and platelets was completely blocked by prior treatment of the test uterus 
with 20/zg of the 5  HT antagonist,  1-benzyl 2,5-dimethyi serotonin in  10 ml of Ringer's 
solution for 15 minutes (8).  (b) Incubation of test plasmas with chymotrypsin,  1 mg per ml, 
for  15  minutes  at  37"C,  a  procedure  which inactivates the uterus-stimulating  activity of 
polypeptides (9), did not decrease the activity of the test plasmas and platelet residues.  (c) 
Plasma potassium concentrations were 2 to 4 meq per liter, far below the level required to 
produce uterus stimulation (10) and did not change during incubation of platelet-rich plasma 
with endotoxin.  (d) Inclusion of atropine in the muscle bath in a concentration which com- 
pletely inhibits the uterus response to acetylcholine (10) was without effect on the response 
to the test plasmas.  (e) The activity which developed in the test plasmas was stable over a 
24  hour  period  at  4°C  indicating  that  labile  uterus-stimulating  factors  appearing  during 
surface activation of human  plasma by glass beads were not involved (11).  (f)  Increase in 
uterus-stimulating activity in plasma was accompanied by reciprocal decrease in the activity 
remaining with the platelets.  (g) Histamine has no effect in this assay system (10). 
Preparation of Plasma.--Rabbit  blood  was  obtained  from  a  freely  bleeding  marginal 
ear vein or by cardiac puncture and delivered directly into siliconized  tubes containing anti- 
coagulant.  Except as specifically indicated  the anticoagulant  used was sodium citrate in a 
final concentration of 0.38 per cent. Heparin in a final concentration of 1 per cent or disodinm 
ethylenediaminetetraacetate  (EDTA)  in a  final concentration  of 0.2  per cent was used  in 
certain  experiments.  Platelet-rich plasma  (PRP)  was  prepared  by  centrifugation  of anti- 
coagulated whole blood in a 15 ml graduated centrifuge tube at 1000 m,~r (225 g at the bottom 
of the tube) for 20 to 30 minutes at 4oC in a refrigerated centrifuge (International, model 2, 
with an 8 place head, catalog No. 269, and 50 ml cups, catalog No. 320).  The superuatant 
plasma from citrated or EDTA blood contained from 400,000  to 800,000 platelets per c. mm 
and  negligible numbers of white and  red cells.  PRP prepared  from heparinized blood con- 
tained substantially fewer platelets, apparently because of increased tendency to spontaneous 
platelet clumping. The total 5HT content of PRP was determined after lysis of the platelets 
by three cycles of freezing and thawing. Centrifugation of PRP at 3000 I~PM (2000 g at the 
bottom of the tube) for 30 minutes yielded platelet-poor plasma which contained  only small 
amounts of 5HT, usually less than 50 NG per ml. 5HIT content of  the platelet residue, de- 
termined after resuspension of the platelets in a volume of saline equal to that of the plasma 
from which they had been sedimented and lysis of the suspension  by freezing and thawing, 
ranged  from 6,000  to  18,000 NG per ml. Mixtures of PRP and  endotoxin were incubated 
at 37°C in a standard bacteriology incubator, and during incubation were constantly rotated 
at  15  lZP~ on a  motor-driven Spinnerette  (model  ST,  New Brunswick  Scientific Co., New 
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Measurement oJ Available Platdel Phospkolipid  (Product I  Substrate Time).--The amount 
of platelet phospholipid available to the clotting process was determined by adding preformed 
product I  and calcium to the test plasma and determining the dotting time of this mixture 
(product I substrate time) (12). Stable product I was prepared from rabbit instead of human 
blood reagents according to the method of Spaet  (13).  The clotting system consisted of 0.1 
ml of a dilution of stable product I, 0.1 ml 0.025 ~x CaCh, and 0.1 ml of test plasma in the. 
platelet-rich state. The dilution of product I  was adjusted to give a minimal product I  sub- 
strate time of 10 seconds or less when tested with plasma in which cephalin in optimum con- 
centrations substituted for platelet phospholipid (14). This dilution was usually 1:10 or 1:20. 
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TExT-Fzo. 1.  Concentration of 5HT in plasma (broken line) or platelets (solid line) during 
incubation of 100 gg per ml of E. coli endotoxin (ll) or saline (O) with platelet-rich rabbit 
plasma. 
When cephalln plasma was serially diluted in platelet-poor plasma,  a  straight  fine log-log 
plot relating product I  substrate time to phospholipid concentration was obtained indicating 
that the test assayed available pbospholipid. 
Measurement  of Bactericidal  Activity  of  Plasma.--Plasma  bactericidal  activity  against 
B. subtilis was determined by a modification of the method of Hirsch (15). Test plasma speci- 
mens were first centrifuged to remove platelets and then serially diluted in twofold steps in 
0.5 ml sterile physiological saline solution containing 0.05 per cent bovine albumin (Armour 
Laboratories, Chicago, Illinois). An 18 hour growth of B. subtilis on trypticase-soy agar was 
suspended  in  physiological  saline  solution  containing  0.05  per  cent  bovine  albumin  and 
turbidometrically  standardized  to  contain  approximately  2000  viable  units  per  nil.  Each 
dilution of test plasma (0.5 ml) was mixed with 0.5 ml of bacterial suspension and incubated 
for 1 hour at 37°C. A mixture of equal parts of bacterial suspension and saline-aibumin diluent 
served as a  control Pour plates were then prepared with 0.1  ml aiiquots of the plasma-B. 
subtilis mixture and melted trypticase-soy agar. Colonies were counted after 24 hours' incuba- 
tion, and the titer of bactericidal activity was expressed  as the reciprocal of the highest dilu- 860  BACTERIAL ENDOTOXIN  AND  RABBIT  PLATELETS.  I 
tion of plasma which effected a 50 per cent or greater reduction in bacterial count as com- 
pared with control plates. 
EXPERIMENTAL 
Rdease  of  5HT  during  Incubation  of Platelets  with  Endotoxin.--Repeated 
experiments have demonstrated  that incubation of citrated rabbit PRP  with 
endotoxin is associated with a  progressive transfer  of 5HT  from platelets to 
plasma. 
TABLE I 
Effect of Endotoxin Concentration on Rdease of Platdet 5HT in Citrated PRP 
Material added 
Saline 
Endotoxin, 1 #g/ml 
Endotoxin, I0 #g/ml 
Endotoxin, 100/zg/ml 
Time incubated I 
rain. 
0 
180 
0 
180 
0 
180 
0 
180 
Platelet 
aggregation* 
0 
+ 
0 
++++ 
Concentration  of 5HT 
r  Plasma  I Platelet residu 
NG/mI  [  NG/ml 
<50  18,500 
225  20,000 
<50 
275 
<50 
225 
<50  20,000 
15,000  1,000 
* 0 to ++++  indicates degree of platelet aggregation. 
Endotoxin was added to rabbit PRP to a final concentration of 100 #g per ml of plasma 
and a second portion of the same PRP was inoculated with a similar volume of saline. Both 
mixtures were rotated in an incubator at 37°C. Aliquots of each were removed  at intervals, 
centrifuged  to sediment platelets, and  5 HT concentrations of the plasma supernate and 
platelet residue determined. 
As is shown in Text-fig. 1, in the specimen of PRP to which saline had been 
added  only  a  small  transfer  of  5HT  from  platelets  to  plasma  occurred.  In 
contrast, in the specimen containing endotoxin a  marked transfer was seen as 
shown  by  a  progressive  increase  in  plasma  5HT  content  and  a  reciprocal 
decrease in the concentration of 5HT in the platelet residue. In many instances 
this transfer was nearly complete after 3  hours' incubation. 
Changes in Platelet Morphology Induced by Endotoxin.--PRP which had been 
incubated  with  endotoxin appeared less opalescent in  the gross than  control 
PRP incubated with saline, and microscopic observations confirmed the notion R. M.  DES PI%EZ,  H. I. HOROV/ITZ, AND  E. W. HOOK  861 
that platelet aggregation accounted for this clearing. Phase microscopic inspec- 
tion of control preparations (Fig. 1A) revealed intact evenly dispersed platelets. 
However, in the endotoxin-PRP mixtures (Fig.  1B)  a  process of aggregation 
and fusion of platelets had occurred to a degree roughly parallel to the release 
of 5HT. Aggregation and fusion of platelets could be differentiated with con- 
siderable confidence from simple clumping in which individual cells remained 
distinguishable. These morphologic changes are similar to those termed viscous 
metamorphosis by others (16). 
Influence  of Concentration  of Endotoxin  and  Type  of Anticoagulant  on  the 
TABLE II 
Effect of Graded Doses of E. coli Endotoxin on Release of 5HT from Platelets in 
Hepariniz~.d PRP 
Material added 
Saline 
Saline 
Endotoxin, 1/~g/ml 
Endotoxin, 10 #g/ml 
Endotoxin, 100/~g/ml 
Time of 
incubstion 
m/n. 
0 
120 
120 
120 
120 
Hate.let 
aggregation* 
NG/ml 
0  35 
0  40 
++  1,000 
@at-q-q  -  1,250 
+q-W+  1,250 
5HT 
Per cent 
Plssma  released~; 
2 
2 
61 
77 
77 
* o to q-W-t-+ indicates degree of platelet aggregation. 
Total 5HT of heparinized plasma was 1625 NG per ml. 
Release  of  Platelet  5HT.--The  interaction  of  endotoxin  and  PRP  is  dose- 
dependent and is strikingly influenced by the type of anticoagulant. 
E. coli endotoxin in graded doses of 100, 10, and 1 #g per ml was added to PRP prepared 
with citrate,  heparin, or EDTA.  Control flasks of PRP were treated with similar volumes 
of saline solution. At intervals varying from 90 to 180 minutes in different experiments the 
specimens were centrifuged to remove platelets and concentrations of 5HT in the supernatant 
plasmas determined. The proportion of 5HT released to total 5HT was determined by meas- 
uring the 5HT concentration remaining in the platelet residue or the total 5HT content in 
an aliquot of untreated PRP. 
As is illustrated in Table I, endotoxin in a  concentration of 1 or 10/~g per 
ml caused almost no platelet aggregation or release of 5HT in citrated PRP, 
whereas endotoxin in a concentration of 100/~g per ml evoked a nearly complete 
release  of  5HT  and  marked  platelet  aggregation.  In  other  experiments  the 862  BACTERIAL  ENDOTOXIN  AND  RABBIT  PLATELETS.  I 
intermediate  dose  of endotox/n  (10/~g  per ml)  demonstrated  slight  activity 
but always substantially less  than the larger dose. 
Table II illustrates  the effects of incubation of endotoxin with heparinized 
PRP. Platelets in heparinized plasma exhibit spontaneous platelet aggregation 
not found in  either  sodium citrate  or EDTA plasma,  and  heparinized  PRP 
contained  substantially  lower  numbers  of  platelets  and  total  5HT.  Never- 
theless,  platelet aggregation and a  substantial  transfer of 5HT from platelets 
to plasma occurred at endotoxin concentrations of 1 ~g per ml (61 per cent of 
platelet  5HT transferred  to plasma)  or  10/zg per ml  (77 per cent of platelet 
TABLE III 
Effect of Temperature on the Interaction of Endotoxin and Platelets 
Temperature 
°c 
4 
4 
4 
37 
37 
37 
Time of incubation 
m/n. 
0 
9O 
180 
0 
9O 
180 
PRP--sallne* 
mixture (control) 
Platelvt  aggregation§  Plasma 5HT 
Nc/,~ 
0 
0  22 
0  325 
0  45 
0  65 
PRP---endotoxin~mixture 
Platelet  aggregation§  Plasma 5HT 
NG/ml 
0  10 
0  37 
0  62 
0  22 
+++  10,000 
+++  8,750 
* Saline, 0.1 ml per ml of PRP. 
E. coli endotoxin, 100/zg per ml PRP. 
§ 0 to +q--F+ indicates degree of platelet aggregation. 
5HT transferred  to plasma)  of heparinized  PRP.  As noted in  the  preceding 
paragraph, 10 #g of endotoxin caused only slight platelet aggregation or release 
of 5HT in citrated PRP. 
When EDTA was used as an anticoagulant, no morphologic change or 5HT 
release  could be demonstrated  at  any of the  three  endotoxin concentrations 
tested. 
Effect  of  Temperature  on  the Endotoxin-Platelet  Interaction.-- 
Citrated PRP was divided into four aUquots, two of which were inoculated with endotoxin, 
100 pg per ml, and two with saline solution. One endotoxin-containing and one saline-con- 
taining aliquot were slowly rotated at 37°C and the other two specimens were rotated at 4°C. 
Specimens were removed at intervals and concentrations of plasma 5HT determined after 
separation of plasma and platelets by centrifugation. 
As is seen in Table  III,  platelet  aggregation and  release  of platelet  5HT 
occurred when endotoxin was incubated  with  PRP at 37°C,  whereas  neither R.  M.  DES  PREZ~  H.  I.  HOROWITZ~  AND  2.  W.  HOOK  863 
morphologic change nor release of 5HT occurred when the reaction was carried 
out  at  4°C.  The  spontaneous  platelet  aggregation observed by others (17)  to 
occur at 4oc did not interfere with these microscopic observations which were 
made after the slides had remained several minutes at room temperature. 
Other Substances Active in Releasing 5HT from Platelets.--Heat-killed E. coli 
in concentration of l0  s cells per ml of PRP  was found to be quite  active in 
releasing  platelet  5HT.  Similar  activity was demonstrated  by equal  concen- 
trations  of  heat-killed  staphylococci,  pneumococci,  and  streptococci,  but 
polysterene latex particles of coccal size were without effect. 
TABLE IV 
The Effect of Endotoxin ca Platelets Suspended in Previously Heated Plasma 
Material added 
Endotoxin,  100 
#g/ml 
Saline solution, 0.I 
ml/ml 
Time 
incubated 
m/n. 
0 
45 
90 
0 
45 
90 
Platelets in previously 
heated* plasma 
Platelet 
iaggregation~ 
0 
0 
+ 
0 
0 
+ 
Plasm 
5HT 
NGIm 
15 
6O 
90 
10 
225 
9O 
L  Platelet 
residue SHT 
I  l¢,G/ml 
7350 
Platelets in unheated plasma 
Platelet 
aggregation 
Plasma 
5HT 
NC/~ 
2O 
42OO 
5850 
0 
++ 
+++ 
Platelet 
residue SHT 
leG~rat 
2200 
* 56  ° for 30 minutes. 
:~ 0 to -{--~+-{- indicates degree of platelet  aggregation. 
Platelet  aggregation and release  of 5HT  as described  by others  (18-20)  in 
the presence of antigen-antibody reactions could also be observed in the system 
used  in  these  experiments.  These  changes  were  observed  after  addition  of 
human  gamma  globulin  and  rabbit  anti-human  gamma  globulin  to  a  non- 
immunized  animal's  plasma  or  after  addition  of human  gamma  globulin  to 
PRP obtained from an animal immunized with human gamma globulin. 
Evidence for the Participation of Plasma Factors in the Interaction of Platelets 
and Endotoxin.-- 
Three aliquots of PRP were centrifuged and the sedimented platelets set aside. Two of the 
plasma supernates were heated at 56°C for 30 minutes, and the third was kept at room tem- 
perature.  After the heated  specimens had returned  to room temperature,  the platelets  were 
resuspended in the plasmas from which they had been removed. Endotoxin in a concentration 
of 100 #g per ml was added to one of the suspensions of platelets in previously heated plasma, 
and to the platelets  suspended in plasma which had been kept at room temperature.  As a 
control, saline was added to the rem,lnlng aliquot of platelets in previously heated  plasma. 864  BACTERIAL  ENDOTOXIN  AND  RABBIT  PLATELETS.  I 
The three aliquots were then incubated at 37°C and samples were removed at intervals for 
determination of content of 5HT in plasma and platelets. 
Heating plasma at 56°C for 30 minutes inactivates or removes some factor 
necessary  for  the  endotoxin-platelet  interaction.  As  shown  in  Table  IV, 
endotoxin in  a  concentration  of  100  #g  per  ml  produced  marked  platelet 
aggregation  and  release  of  5HT  when  incubated  with platelets  resuspended 
in  unheated  normal  plasma,  but  had  no  apparent  effect  on  platelets  in 
plasma previously heated  at  56°C for 30 minutes.  The plasma factor that is 
10,000 
5,OOO  - 
Time (min.) 0 ~  15  30  45  60  75 
Platelet  aggregation  0  ++  +**  ~ +~  ++++ 
TExT-FIG. 2.  Time of appearance of platelet aggregation and release of 5HT after ad- 
dition of 100 #g per ml of E. coli endotoxin to platelet-rich rabbit plasma. 0 to  ++++ 
indicates degree of platelet aggregation. 
removed or inactivated by heating at 56°C for 30 minutes is not restored by 
addition of fresh pooled guinea pig serum. 
A  lag period of 30  to  60 minutes  has  been  consistently observed between 
addition of endotoxin to PRP and the occurrence of platelet aggregation and 
release of 5HT. This is illustrated in the experiment depicted in Text-fig. 2 in 
which  observations  were  made  every  15  minutes.  Morphologic  changes  in 
platelets  were not observed until  30 minutes after addition of endotoxin and 
appreciable  amounts  of plasma  5HT did  not  appear  until  60  minutes  after 
endotoxin had been added. 
It is of interest that the lag period between addition of endotoxin and release 
of platelet  5HT could be  shortened  by incubation of endotoxin with plasma 
prior to addition of platelets. 
Three aliquots of PRP were centrifuged and the sedimented platelets set aside. Endotoxin 
in a concentration  of 100/~g per ml was added to the supernatant plasma from the first aliquot, 
saline solution was added to the second aliquot, and nothing was added to the third. The three R. M. DES PREZ~  H. I. HOROWITZ,  AND  E. W. I~00K  865 
aliquots of plasma were rotated at 37°C for 90 minutes.  The platelets were then resuspended 
in the plasma aliquots from which they had been removed, and at this time 100/zg per ml of 
endotoxin was added to the third previously untreated aliquot. All specimens were  again 
rotated at 37°C and samples removed at intervals, spun to remove platelets, and the super- 
natant plasma assayed for 5HT content. 
When platelets and endotoxin were added to plasma which had been incu- 
bated at 37°C for 90 minutes, the usual lag period between addition of endo- 
toxin and the appearance of platelet aggregation or release  of platelet 5HT 
5,0011 
-.  4,00( 
"~  3,000 
2,000 
1,11110 
Time (min.~ 
A 
/ 
/ 
/  B/° 
i  15  30 
Platelet  aggregation: A  ++  ++++  +++÷ 
B  0  +  ++ 
C  0  0  0 
T~xT-F~G. 3. Time of appearance of platelet aggregation and release of 5HT  (.4) after 
resuspension  of platelets in plasma previously incubated with I00/zg per ml of E. coli en- 
dotoxin at 37°C for 90 minutes,  (B) after addition of 100/zg per ml of E. coli endotoxin to 
platelets resuspended  in plasma previously incubated at 37°C with 0.I ml saline per ml for 
90 minutes, and (C) after resuspension of platelets in plasma previously incubated with saline 
solution. 0 to -i--{-~-b indicates degree of platelet aggregation. 
was  observed  (Text-fig.  3).  In  contrast,  the  specimen  of plasma previously 
incubated with  endotoxin  demonstrated  moderate  platelet  aggregation  and 
a  high concentration of plasma 5HT  as soon as 15  minutes  after resuspension 
of platelets and maximum changes had occurred by 30 minutes. No change in 
plasma 5HT occurred in the saline control over the period of observation. 
Platelet aggregation and  release of 5HT  induced by addition of  N..  coli  or 
staphylococci to rabbit PRP  could be inhibited by prior absorption of plasma 
with bacterial cells. 
Platelets were  removed from four aliquots of PRP  by centrifugation. Two  aliquots of 
supematant plasma were incubated at 37°C for 90 minutes with thrice washed  heat-killed 
E.  coli in a  concentration of l0  s cells per ml, and the other two aliquots were  incubated 
with saline solution as controls. The plasmas were centrifuged  to remove  the bacterial cells, 
and the platelets then resuspended  in their  original plasmas. Heat-killed E.  coli in a con- 866  BACTERIAL  ENDOTOXIN  AND  RABBIT  PLATELETS.  I 
centration of l0  s cells was then added to one of the E. coli absorbed and one of the control 
specimens, and a similar concentration of heat-killed S. aureus was added to the other E. coli 
absorbed  and  the other control specimen.  All four  suspensions were  then reincubated  at 
37°C for 90 minutes. Platelet morphology and plasma 5HT concentrations were  determined 
immediately after the final addition of E. coli and again after 90 minutes' incubation. 
Prior absorption of plasma with E. coli greatly diminished the response of 
resuspended platelets to subsequent chalenge with homologous or heterologous 
bacterial cells (Table V). 
Release of Plalelet Phospholipid  during Incubation  of PRP with Endotoxin.-- 
TABLE  V 
The Effect of A bsorption of Plasma with Heat-Killed E. coli on Response of Resuspended Platelas 
to Homologous  or Iteterologous  Bacterial Cells 
Challenge* 
E. co// 
E. coli 
Staphylococci 
Staphylococci 
Time 
mm. 
o 
90 
o 
90 
Platelets in plasma absorbed/with 
g. coli~ 
Platelet 
aggregation[[ 
++ 
+ 
+ 
No platelets 
seen 
Plasma 
5HT 
NG ml 
7OO 
2,250 
825 
3,350 
Plateletsinplasma treated 
with saline§ 
Platelet aggregationl[ 
+ 
++++ 
+ 
No platelets 
seen 
Plasma 
5HT 
NG/ml 
225 
10,500 
'  275  ! 
I  13,500 
i 
I 
* 10  s heat-killed bacterial cells per ml. 
Plasma was absorbed with 10  a heat-killed E. coli per ml, 37°C for 90 minutes, centrifuged; 
platelets then resuspended in absorbed plasma. 
§ Plasma was mixed with 0.05 ml of saline solution per ml of plasma, incubated at 37°C 
for 90 minutes, centrifuged; platelets then resuspended in plasma. 
[] 0 to ++++  indicates degree of platelet aggregation. 
The intrinsic or blood coagulation process is classically represented in three 
stages,  thromboplastin  generation,  conversion of prothrombin  to  thrombin, 
and conversion of fibrinogen to fibrin.  Each successive stage is catalyzed in 
part by the product of the preceding one. When fully formed blood thrombo- 
plastin (21) is supplied and prothrombin and fibrinogen are present in normal 
amounts, the second and third stages proceed to completion in about 10 seconds 
or less. Any time beyond this period necessary for normal blood or plasma to 
coagulate is a  measure of the time required for the first stage to proceed to 
completion under the experimental circumstances. The first stage is thought 
to involve two parallel processes which interact at their completion. On  the 
one hand an interaction of several first stage factors forms a powerful coagula- 
tion activity termed product I  (21),  and on the other hand intact platelets 
make phospholipid available to the clotting process (22). Blood thromboplastin R.  M.  DES  PREZ,  H.  I.  HOROWITZ,  AND  E.  W.  HOOK  867 
results from the interaction of product I  and available platelet phospholipid 
in the presence of factor V and calcium (21). 
McKay and associates (23) and Robbins and Stetson (17) have demonstrated 
that bacterial endotoxin shortens the coagulation time of recalcified citrated 
plasma  or  whole  blood  in  siliconized  tubes.  This  coagulation  acceleration 
occurred only when platelets were present, and was necessarily a function of a 
shortened first stage. The acceleration of the first stage of coagulation induced 
by endotoxin could be mediated through an acceleration of product I formation, 
or through an effect on platelets to make phospholipid available. If the coagula- 
tion-accelerating effect of endotoxin should obtain when preformed product I 
TABLE VI 
The Effect of E. coU Endotoxin on Product I  Substrate Time (A~ailable Phospholipid) of PRP 
Product I  substrate tame 
Time of 
incubation 
PRP +  e~dotoxin  PRP -b endotoxin  PRP -b saline  Plasma +  cephMin q- 
100 ~g/ml  10 ~g/ml  endotoxin 100 ~g/ml 
mm. 
0 
15 
30 
45 
6O 
180 
SeC. 
30.0 
22.8 
19.8 
13.0 
10.0 
13.9 
se.c. 
32.0 
28.3 
26.3 
19.2 
17.4 
10.2 
$$~g. 
31.3 
30.1 
27.6 
25.5 
25.0 
23.0 
sec. 
10.7 
10.4 
is supplied in excess, this would indicate that the acceleration is consequent to 
an effect on platelets which increases the availability of phospholipid for the 
clotting process. 
PRP was incubated at 37°C with endotoxin in concentrations of 100 and 10 #g per ml. 
Aliquots were removed at intervals and assayed for product I substrate activity (available 
phospholipid) by determining  the dotting time after addition of product I and calcium. Prod- 
duct I substrate times were also determined on specimens of platelet-poor plasma containing 
brain cephalin as a phospholipid substitute during the course of incubation with endotoxin. 
Addition  of preformed product I  and  calcium  to  plasma  in  which  added 
cephalin provided freely available phospholipid resulted in dotting in approxi- 
mately 10 seconds, and incubation of the mixture of plasma and cephalin with 
endotoxin did not further accelerate coagulation after addition of product I 
and calcium (Table VI). However, when product I  and calcium were added to 
plasma  in which  intact platelets  served as  the  only source of phospholipid, 
dotting was delayed approximately 20 seconds, this prolongation representing 
the time necessary for platelets to release phospholipid. The product I substrate 
time  of  PRP  incubated  with  10  or  100  #g  per  ml  of g.  coli  endotoxin 868  BACTERIAL  EN-DOTOXIN  AND  RABBIT  PLATELETS.  I 
progressively decreased to an extent proportional to the duration of incubation, 
and  by 60 minutes  sufficient  phospholipid  had  become available so  that  its 
concentration was no longer the rate-limiting factor. Participation of surface- 
activated factors seemed excluded by the finding that maximal surface activa- 
tion  (agitation  of  PRP  with  25  per  cent  by  volume  Celite  powder,  Johns 
Manville) did not appreciably alter the product I  substrate time. 
Release of Platelet BacteHcidins during Incubation of PRP with Endotoxin.-- 
Hirsch (15)  and others (24)  have presented evidence for a bactericidal system 
contained in platelets which is active against certain Gram-positive organisms, 
TABLE VII 
Morphologic Change and Release of B. subtilis Bacteriddins  and 5ItT During Incubation of 
PRP with E. coil Endotoxin 
Material  added 
3afine 
gndotoxin, 100 
#g/ml 
Time of incubation 
men. 
0 
90 
180 
0 
90 
180 
Platelet 
aggregation* 
0 
+ 
++ 
Titer of bactericidal 
activity in plasma~ 
8 
128 
128 
Plasma 5HT 
NG/ml 
10 
10 
57 
10 
7,500 
11,500 
* 0 to ++++  indicates degree of platelet 
Reciprocal of highest twofold dilution of 
of B. subtilis in a concentration of about 2000 
aggregation. 
plasma producing more than  50 per cent kill 
viable units per ml. 
notably  B.  subtilis.  Incubation  of endotoxin  with  rabbit  PRP  is  associated 
with a  progressive transfer of bactericidal  activity from platelets  to plasma. 
An aliquot of PRP was incubated with endotoxin, 100/zg per ml at 37°C. A control aliquot 
was incubated with saline solution. Samples  of PRP were removed at zero, 90, and 180 minutes 
after incubation and centrifuged to remove platelets. The fiter of bactericidal activity against 
B. subtilis in the plasma supernate was determined by a serial dilution technique described 
under Methods. 
No change in fiter of plasma bactericidal activity was observed in the saline- 
treated aliquots  (Table VII). However, in the aliquot of PRP incubated with 
endotoxin  the  bactericidal  activity in  the  plasma  supernate  increased  more 
than  16-fold and 5HT appeared in  the plasma in increasing  amounts.  A  de- 
crease in bactericidal activity in the platelet residue  occurred concomitantly 
with  the  increase  in  bactericidal  activity of plasma.  Additional  experiments 
have shown  that  the  endotoxin-induced  release of B.  subtilis  bactericidins  is 
also  influenced  by  dose  of  endotoxin,  temperature  of incubation,  and  anti- R. M. DES PREZ, H. I. IIOROWITZ, AND  E. W. HOOK  869 
coagulant, and is dependent on the presence of heat-labile plasma factors in a 
manner quite similar to that previously described for the release of 5HT. 
DISCUSSION 
A  reaction  between  endotoxins  of  Gram-negative  bacteria  and  platelets 
leading to platelet aggregation and release of platelet factors, as demonstrated 
by the in ~tro  studies described in this report, may be of importance in the 
pathogenesis  of certain biologic events  observed in  the intact  host  after in- 
jection of endotoxin. 
Platelet aggregates have been detected in the circulating blood of rabbits inoculated 
intravenously with endotoxin (3), and it is reasonable to postulate that these aggre- 
gates as well as altered individual platelets are trapped in small blood vessels in vascu- 
lar beds. The characteristic granulocytopenia observed after injection of endotoxin 
has been attributed to sequestration of white cells within pulmonary blood vessels 
and spleen (1, 25), and it is likely that the mechanism of thrombocytopenia has many 
similarities.  Platelet and leukocyte thrombi in small blood  vessels  have  been  ob- 
served after single injections of endotoxin, and are among the most prominent patho- 
logical findings in the local and generalized  Shwartzman phenomena, occurring prior 
to overt vascular rupture (25). 
The transfer of 5HT from platelets to plasma during incubation of plateletorich 
plasma with endotoxin in ~tro closely parallels the extent of platclet aggregation. As 
mentioned previously, Davis, Meeker, and McQuarrie (3) have presented evidence 
that platelet aggregates appear in circulating blood of dogs after injection of endo- 
toxin. Other studies (4-5) have clearly shown that increases  in plasma 5HT concen- 
trations also occur following endotoxin injections in dogs and rabbits. Although the 
increase in plasma 5HT concentration is small and transient, the concomitant fall in 
whole blood 5HT content is much more extensive, at times exceeding 80 per cent of 
control whole blood 5HT values (6). This decrease in whole blood 5HT is probably due 
both to transfer of 5HT from platelets to plasma with subsequent rapid enzymatic 
degradation, and to removal of platclet-bound 5HT as the sequestration of platelets 
develops. 
Thomas and associates (26), as part of an extended investigation of the mechanisms 
underlying  the  Shwartzman phenomena, have demonstrated  that  both  5HT and 
endotoxin greatly enhance the necrotizing and vasomotor effects of epinephrine and 
norepinephrine on small blood vessels. These observations led to the hypothesis that 
part of the effect of endotoxin may be to make 5HT available in or around the walls of 
blood vessels for an action in concert with epinephrine.  Although speculative, this 
idea blends well with the evidence that endotox~-platelet interactions in ~tro and 
i~ ~ro result in release of 5HT, and also with the protective action of antiserotonin 
compounds against the lethal effects of endotoxin  (27). 
A recent review by Gilbert (28) has compiled a large body of experimental evidence 
indicating that profound vasomotor changes and injury to the microclrculation occur 
after injection of bacterial endotoxin. These changes are rapid in onset, and include 
vasoconstriction followed by vasodilatation, profound systemic hypotension, and in- 870  BACTERIAL ENDOTOXIN AND  RABBIT PLATELETS. I 
crease in portal and pulmonary vascular resistance and organ weight in certain species. 
Hinshaw and associates  (29), in studying the effects of endotoxin on the isolated per- 
fused dog lung, noted that the increase in organ weight and vascular resistance which 
occurred when endotoxin was perfused in whole  blood  or cell-rich  plasma did  not 
obtain  when the  endotoxin-containing perfusate was cell-poor  plasma, dextran,  or 
gelatin.  Since 5HT itself  causes entirely similar changes  in pulmonary vascular re- 
sistance and lung weight (30-32),  it seems possible that the substance in blood or cell- 
rich plasma necessary/or this activity of endotoxin may be platelet 5HT. 
The prominence of platelet-leukocyte thrombi in the local and generalized  Shwartz- 
man phenomena and their occurrence after single injections of endotoxin (25) have led 
several investigators to study endotoxin-induced  changes  in the coagulation system. 
Among these,  McKay and associates (23, 25) and Robbins and Stetson (17) demon- 
strated that in viva injections  of endotoxin and in vitro incubation of whole blood or 
plasma with endotoxin were followed by shortening of the coagulation time as meas- 
ured in siliconized  tubes. These in vitro  changes  occurred only when platelets were 
present, and are compatible with the concept that the endotoxin effect was mediated 
by release  of platelet phospholipid, as demonstrated in the present studies. In this 
regard, Spaet (33) has demonstrated that intravenous injection of crude phospholipid 
in rabbits causes a transient but marked hypercoagulable state. This systemic change 
might be of great local importance if vascular injury, vasospasm, and platelet aggre- 
gates are also present to favor the development of intravascular thrombosis. 
The rather constant  lag period  between  addition  of endotoxin  and  release 
of 5HT from platelet-rich  plasma in  vitro  is  discordant  with  the  immediate 
changes  in  plasma  and  whole  blood  5HT  following  endotoxin  injections  in 
vivo. This disparity may be more apparent than real, since all the anticoagulants 
used in in vitro studies inhibit platelet changes to one degree or another. More- 
over, in the in vivo systems it is likely that initial platelet changes result in the 
appearance of thrombin which itself is an extremely active promoter of platelet 
viscous  metamorphosis  and  might  lead  to  an  autocatalytically  accelerated 
reaction. 
The  findings  presented  herein  are  compatible  with  the  concept  that  the 
effect of endotoxin  on platelets  involves immune mechanisms.  Antigen-anti- 
body  reactions  have  been  demonstrated  to  produce  platelet  aggregation, 
release of histamine, and release of 5HT in vitro  (18,  19).  Two groups (20,  19, 
34) have reported that injections.of antigen in sensitized animals are followed 
by changes in whole blood and plasma 5HT content entirely similar in magni- 
tude  and  time of onset  to  those  observed after injection  of endotoxin.  Two 
recent  studies  of  the  action  of antigen-antibody  reactions  on  platelets  have 
been reported, one (35)  measuring platelet aggregation and the other (36,  37) 
release  of platelet  histamine.  Both  of  these  studies  presented  evidence  that 
plasma factors were necessary,  but differed as to whether  these factors were 
components  of  complement  or  represented  an  analogous  but  separate  lyric 
system. The present studies do not allow a decision as to whether the plasma R.  M.  DES  PREZ, H.  I.  HOROWITZ, AND E.  W.  HOOK  871 
factor involved is complement. Heating plasma at 56°C for 30 minutes resulted 
in loss of this plasma activity and addition of guinea pig complement did not 
restore it. However, fibrinogen is precipitated by heating at 56°C for 30 minutes, 
and Jackson has presented evidence that fibrinogen is necessary for thrombin- 
induced platelet aggregation (38). 
SUMMARY 
Incubation of platelet-rich  rabbit  plasma  with E.  coli  endotoxin at  37°C 
results in platelet aggregation and transfer of platelet 5-hydroxytryptamine to 
plasma.  Release  of  5HT  is  influenced  by  dose  of  endotoxin,  type  of 
anticoagulant, and temperature of incubation. A  heat-labile plasma factor is 
necessary for the platelet-endotoxin interaction. Additional studies have shown 
that incubation of endotoxin with platelet-rich rabbit plasma also results in 
release of platelet phospholipid and bactericidins active against B. subtilis. 
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EXPLANATION  OF PLATE 88 
FIG.  1.  Morphology  of  platelets  after  incubation for  180  minutes with  saline 
solution (A) or 100 ~g per ml of E. coli endotoxin (B). Phase contrast. ×  1250. THE JOURNAL  OF EXPERIMENTAL  MEDICINE  VOL.  114  PLATE 88 
FIG. 1 
(Des Prez et  al.:  Bacterial endotoxin and rabbit platelets. I) 